SSR-181507

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSSR-181507
Drug Alias NameSSR-181507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsDopamine D3 receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A